Published online 4 November 2008                                                     Nucleic Acids Research, 2008, Vol. 36,  22 e151
                                                                                                                  doi:10.1093/nar/gkn811

 novel method generate unmarked
gene deletions intracellular pathogen
Rhodococcus equi using 5-fluorocytosine
conditional lethality
R. van der Geize1,*, W. Jong1, G.  Hessels1,  W. F. Grommen2,   C. Jacobs2 L. Dijkhuizen1
1
 Groningen Biomolecular Sciences Biotechnology Institute (GBB), Department Microbiology, University Groningen, Kerklaan 30, 9751 NN Haren 2Intervet Schering-Plough Animal Health, Bacteriological R&D,
Wim KoÂ¨rverstraat 35, Postbus 31, 5830 AA Boxmeer, Netherlands

Received September 16, 2008; Revised Accepted October 10, 2008



ABSTRACT                                                                        INTRODUCTION novel method efficiently generate unmarked                                 important molecular tool functional genomics stu- frame gene deletions Rhodococcus equi                                 dies targeted inactivation gene 
developed, exploiting cytotoxic effect                                   Ideally, unmarked gene deletions constructed using 5-fluorocytosine (5-FC) action cytosine                               positive selection step rare second recombination
deaminase (CD) uracil phosphoribosyltransfer-                               event. sacB gene Bacillus subtilis                                                                                 widely used suicide genes, conferring sucrose sensitivity
ase (UPRT) enzymes. opportunistic, intracellular
                                                                                Gram-negative bacteria (1,2). Previously, pathogen R. equi resistant high concentrations
                                                                                reported use sacB counter-selection eï¬ƒciently 5-FC. Introduction Escherichia coli genes                                 generate unmarked gene deletions Rhodococcus erythro-
encoding CD UPRT conferred conditional                                      polis (3). method subsequently applied lethality R. equi cells incubated 5-FC.                                 Rhodococcus species (4â€“6). Sucrose sensitivity exemplify use codA::upp cassette                               sacB reported mycolic acid 
counter-selectable marker, unmarked frame                                 taining actinobacteria, e. Corynebacterium glutamicum
gene deletion mutant R. equi constructed.                                Mycobacterium sp. (7). Despite considerable eï¬€orts, supA supB genes, putative cho-                                unable apply sacB counter-selectable
lesterol catabolic gene cluster, efficiently                               marker Rhodococcus equi, lack sucrose sen-
deleted R. equi wild-type genome. Pheno-                               sitivity. Similar observations reported typic analysis generated "supAB mutant                                   Streptomyces lividans (7). sacB counter-selection
confirmed supAB essential growth                                generally applicable Gram-positive
R. equi cholesterol. Macrophage survival assays                              bacteria, like B. subtilis. B. subtilis, mazF, encoding
revealed "supAB mutant able                                      toxin, used suicide marker generate
                                                                                unmarked gene deletion mutants (8). method relies
survive proliferate macrophages comparable
                                                                                availability tightly regulated, inducible pro- wild type.  cholesterol metabolism does                                 moter, limiting applicability bacteria devel- appear essential macrophage                                       oped molecular toolboxes. use alternative suicide
survival R. equi. CD-UPRT based 5-FC                                     genes reported  e.g. glkA, pyrF, upp counter-selection useful asset                                  rpsL (9â€“12). major drawback markers,  generation unmarked frame gene deletions                               function glkA, pyrF, upp actinobacteria  actinobacteria                              strA null mutants, respectively, necessitating construc-
generally appear 5-FC resistant 5-FU                                  tion, availability, null mutant strain sensitive.                                                                      mutated. PCR-targeted gene replacement strategy 

 correspondence addressed. Tel: +31 50 363 2257; Fax: +31 50 363 2254; Email: r.van.der.geize@rug.nl
 authors wish known  opinion, authors regarded joint Authors.

ÃŸ 2008 Author(s) Open Access article distributed terms Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ nc/2.0/uk/) permits unrestricted non-commercial use, distribution, reproduction medium, provided original work properly cited.
 e151 Nucleic Acids Research, 2008, Vol. 36,  22                                                             PAGE 2 10

 reported streptomycetes relies avail-       M. tuberculosis H37Rv, mce4 cluster ability ordered genomic libraries eï¬ƒciently generate       H37Rv essential growth cholesterol.
mutants (13). method,  requires labo-                R. equi strain 103S genome sequence recently rious extra round mutagenesis remove resist-           available (http://www.sanger.ac.uk/Projects/
ance marker integrated genome generate               R_equi/). Proper genome annotation identiï¬?cation
unmarked mutants. Recently, simpliï¬?ed method               pathogenicity genes requires simple methods gene
marker removal actinomycetes using Flp recombinase            deletion mutagenesis. method isolation gene described (14).                                         deletion mutants R. equi double homologous
   Cytosine deaminase (CD, EC 3.5.4.5) uracil phos-          recombination strategy ï¬?rst reported Navas et al.
phoribosyltransferase (UPRT, EC 2.4.2.9) enzymes             (27). improved method, using lacZ counter-
involved pyrimidine salvage pathway, converting           selectable marker, subsequently reported Jain
cytosine uracil dUMP. CD activity              et al. (33). methods,  involve screen- certain prokaryotes lower eukaryotes.           ing handling large numbers colonies select genes encoding activities Escherichia coli, codA        rare second recombination event (34,35). upp, respectively, cloned characterized        introduction codA::upp cassette confers
(15,16). Interestingly, microorganisms expressing CD         5-FC sensitivity R. equi allowing positive selection vert innocuous cytosine analog 5-ï¬‚uorocytosine               targeted gene deletion mutants. simple eï¬ƒcient
(5-FC) 5-ï¬‚uorouracil (5-FU), highly toxic com-            procedure generate unmarked frame gene deletions
pound lethal living cells. cytotoxicity largely        R. equi reported, exempliï¬?ed construction exerted following UPRT mediated conversion 5-FU               characterization supAB mutant. 5-ï¬‚uoro-dUMP, irreversibly inactivates thymi-
dylate synthase inhibiting RNA DNA synthesis
(17). Heterologous expression E. coli codA shown          MATERIALS METHODS confer 5-FC sensitivity mammalian cells, ordinarily        Culture media growth conditions R. equi strain RE1 producing CD (18). Concomitant expression E. coli
                                                                 Virulent R. equi wild type strain RE1 isolated CD UPRT fusion protein, encoded codA::upp,           foal pyogranulomatous pneumonia September shown enhance 5-FC cytotoxicity (19).         2007 Netherlands. R. equi strains grown recent study pyrimidine salvage Streptomyces spe-        308C (200 r.p.m.) Luria-Bertani (LB) medium cies indicated lack CD activity sensitivity     mineral acetate medium (MM-Ac). MM-Ac contained
5-FU (20). actinobacteria, like Rhodococcus           K2HPO4 (4.65 g/l), NaH2PO4  H2O (1.5 g/l), sodium-
species, shown 5-FU sensitive (21,22).           acetate (2 g/l), NH4Cl (3 g/l), MgSO4  7H2O (1 g/l), thia- Nocardia species certain Mycobacterium strains,         (40 mg/l, ï¬?lter sterile) Vishniac stock solution  5-FU resistant, mycobacteria           (1 ml/l). Vishniac stock solution prepared follows
strains highly 5-FU sensitive (21).                         [modiï¬?ed (36)]: EDTA (10 g/l) ZnSO4  7H2O
   R. equi facultative intracellular pathogen causes   (4.4 g/l) dissolved distilled water (pH 8 using
fatal pyogranulomatous bronchopneumonia young                 2 M KOH).  CaCl22H2O (1.47 g/l), MnCl27
foals. emerging opportunistic pathogen          H2O (1 g/l), FeSO47H2O (1 g/l), (NH4)6 Mo7O244 H2O
immuno-compromised humans, particularly HIV infected             (0.22 g/l), CuSO45H2O (0.315 g/l) CoCl26 H2O
patients (23,24). addition pathogenic life-style, R.   (0.32 g/l) added order pH 6 ï¬?nally
equi common soil-dwelling microorganism capable          stored pH 4. growth solid media Bacto-agar
rapid growth soil manure, using plant animal          (15 g/l) added. 5-Fluorocytosine (Sigma-Aldrich
sterols sole carbon energy sources (25,26).               Chemie, Zwijndrecht, Netherlands) 5-ï¬‚uorouracil
Knowledge sterol metabolism R. equi extremely           (Sigma-Aldrich) stock solutions (10 mg/ml) prepared
limited. far, gene encoding proposed ï¬?rst        distilled water, dissolved heating 508C, ï¬?lter-
step cholesterol degradation, cholesterol oxidase             sterilized added autoclaved media.
(choE), identiï¬?ed inactivated R. equi               growth cholesterol, R. equi strains inocu-
(27,28). cholesterol catabolic gene cluster           lated 25 ml MM-Ac liquid medium grown 24 h
identiï¬?ed closely related Rhodococcus jostii RHA1         200 r.p.m. 308C. pre-culture (0.5 ml) used
(6,29). cluster encodes putative cholesterol         inoculate 50 ml MM medium containing 0.5 g/l cho-
uptake  designated mce4 operon. â€˜Mammalian                lesterol (Sigma-Aldrich) sole carbon energy source
cell entryâ€™ (mce) genes critical virulence factors    ï¬?nely dispersed sonication. Regular
intracellular pathogen Mycobacterium tuberculosis (30)           turbidity (OD600nm) measurements cholesterol grown  interestingly, mce1 mce4 strains M. tuber-           cultures possible high background culosis H37Rv showed attenuated survival mice (31).           cholesterol suspension. Protein content culture supAB genes mce4 operon              used measure biomass formation encode permease subunits cholesterol uptake           determined follows. sample (0.5 ml) culture (6). supAB mce4 genes shown               pelleted centrifugation (5 min 12 000g) thor- essential growth R. jostii RHA1 cholesterol         oughly resuspended 0.1 ml Bacterial Protein Extraction
(6). Pandey Sassetti (32) recently conï¬?rmed             Reagent (B  Pierce, PerBio Science Nederland B.V.,
cholesterol used carbon energy source             Etten-Leur, Netherlands).  0.4 ml distilled water
 PAGE 3 10                                                           Nucleic Acids Research, 2008, Vol. 36,  22 e151

 added suspension vortexed incubated          Construction plasmids pSET-Pkan-codA, room temperature 5â€“10 min. aliquot 160 ml           pSET-Pkan-codAupp pSelAct mixed 640 ml distilled water 200 ml           aphII promoter region ampliï¬?ed pRESQ
protein assay reagent (BioRad) added. Protein            (37) using PCR primers Pkan-F Pkan-E5-R
tent sample determined using bovine serum             (Table 1). obtained PCR product 367 bp albumin (BSA) standard described                  blunt-ligated EcoRV digested pBluescript(II)KS
manufacturer.                                                    (Stratagene), resulting pBs-Pkan. SalI/NotI restric-
                                                                 tion released 431 bp fragment comprising aphII pro-
                                                                 moter cloned SalI/NotI digested
Cloning, PCR chromosomal DNA isolation
                                                                 pORF-codA::upp (InvivoGen, San Diego, USA), yielding
E. coli DH5a used host cloning procedures.        plasmid pORF-Pkan-codAupp. Pkan-codA::upp
Restriction enzymes obtained Fermentas                 cassette subsequently isolated pORF-Pkan-
GmbH (St Leon-Rot, Germany). PCR performed                codAupp 2.4 kb SmaI/NheI fragment ligated reaction mixture (25 ml) consisting Trisâ€“HCl (10 mM,        EcoRV/XbaI digested pSET152 resulting plasmid
pH 8), 10  High-Fidelity polymerase buï¬€er (Fermentas),          pSET-Pkan-codAupp (Figure 2). Pkan-codA cassette
dNTPs (0.2 mM), DMSO (2 ), PCR primers (10 ng/ml                 (1733 bp) ampliï¬?ed pSET-Pkan-codAupp using  Table 1) High-Fidelity polymerase enzyme               primers Pkan-F codA-R2 (Table 1) ligated (1â€“2 U, Fermentas). colony PCR, cell material            EcoRV digested pSET152, resulting pSET-Pkan-codA
mixed 100 ml chloroform 100 ml 10 mM              (Figure 2). Suicide plasmid pSelAct (Figure 3) 
Trisâ€“HCl pH 8, vortexed vigorously centrifuged               structed ligating 2.4 kb Klenow-treated EcoRI/NheI
(2 min 14 000g). sample upper water phase            fragment pORF-Pkan-codAupp SspI digested
(1 ml) subsequently used template PCR. Chro-          pBs-Apra-ori dephosphoryated alkaline phospha-
mosomal DNA R. equi cell cultures isolated using          tase. Plasmid pBs-Apra-ori constructed GenElute Bacterial Genomics DNA Kit (Sigma-                  pBluescript(II)KS bla cassette removed
Aldrich) according instructions manufacturer.      BspHI, followed Klenow treatment replaced
                                                                 apramycin-oriT cassette obtained 1.3 kb XbaI
                                                                 fragment (Klenow treated) pIJ773 (13).
Electrotransformation R. equi strain RE1
                                                                 Macrophage survival test
R. equi strain RE1 cells transformed electropora-
tion essentially described (27). Brieï¬‚y, cell cultures   human monocyte cell line U937 (38) used test
grown 50 ml LB 308C OD600 reached 0.8â€“1.0.           survival R. equi strains. monocytes grown cells pelleted (20 min 4500g) washed             RPMI 1640 (Invitrogen) + NaHCO3 (1 g/l) + sodium
twice 10  ice-cold glycerol. Pelleted cells            pyruvate (0.11 g/l) + glucose medium (4.5 g/l) (RPMI suspended 0.5â€“1 ml ice-cold 10  glycerol               1640 medium), buï¬€ered 10 mM HEPES (Hopax
200 ml aliquots ice. MilliQ-eluted plasmid           ï¬?ne chemicals, Taiwan) supplemented penicillin
DNA (5â€“10 ml; GenElute Plasmid Miniprep Kit, Sigma-              (200 IU/ml), streptomycin (200 IU/ml) 10  fetal
Aldrich) added 200 ml cells 2 mm gapped cuv-           bovine serum (FBS). cells grown suspension
ettes. Electroporation performed single pulse      378C 5  CO2. macrophage survival assay,
12.5 kV/cm, 1000 
 25 mF. Electroporated cells          monocytes grown days described
gently mixed 1 ml LB medium allowed recover           culture medium replaced fresh cul- 2 h 378C 200 r.p.m. Aliquots (200 ml)            ture medium cells activated overnight plated LB agar medium containing apramycin                  phorbol 12-myristate 13-acetate (60 ng/ml, PMA, Sigma-
(50 mg/ml; Duchefa Biochemie, Haarlem, Nether-               Aldrich) induce diï¬€erentiation macrophages.
                                                                 diï¬€erentiated cells spun (5 min 200g)
lands). Transformants appeared 2â€“3 days incuba-
                                                                 pellet suspended fresh, antibiotic free
tion 308C. transformation eï¬ƒciency                                                                  RPMI 1640 medium 10  FBS. strain non-replicative plasmids integrating homologous
                                                                 tested, tube containing 10 ml cell suspension
recombination  10 transformants/mg plasmid DNA.
                                                                 (106 cells/ml) inoculated R. equi, pre-grown                                                                  nutrient broth (Difco, Detroit, MI., USA) 378C, 5-Fluorocytosine positive selection R. equi                   multiplicity infection (MOI) approximately 10 bac-
                                                                 teria macrophage. bacteria incubated R. equi transformants inoculated LB liquid               macrophages 1 h 378C 5  CO2. medium (25 ml) grown overnight (20â€“24 h) 308C             medium replaced 10 ml RPMI 1640 medium sup- 200 r.p.m. 5-FC selection performed plating           plemented 10  FBS 100 mg/ml gentamycin 100 ml aliquots dilution series (10 1 10 3 MM-Ac      incubated 1 h kill extra-cellular bacteria.
medium) grown culture MM-Ac agar plates              macrophages  internalized R. equi) spun
supplemented 5-FC (100 mg/ml). Dilution cul-         (5 min 200g) pellet suspended ture prior plating crucial eï¬€ective 5-FC selec-       40 ml RPMI 1640 medium, buï¬€ered 10 mM HEPES
tion. 5-FC resistant colonies appeared 2â€“3 days         supplemented 10  FBS gentamycin
incubation 308C.                                              (10 mg/ml). suspension divided culture
 e151 Nucleic Acids Research, 2008, Vol. 36,  22                                                                   PAGE 4 10


bottles (10 ml  incubated 378C 5  CO2. 4, 28, 52 76 h macrophages  culture
bottle strain) spun (5 min 200g) pellet washed twice 1 ml antibiotic free RPMI
1640 medium. Finally pellet lysed 1 
Triton X-100 (Sigma-Aldrich) 0.01 M phosphate buf-
fered saline, followed live count determination (plate
counting).

Culture media growth conditions 5-FC selection actinobacteria
Actinobacterial strains (Table 2) grown late
exponential phase shaken liquid cultures complex
medium 308C, Amycolatopsis methanolica Mycobacterium smegmatis grown 378C. Tryptic Soy Broth (TSB) used Corynebacter-
ium glutamicum, Arthrobacter globiformis, Amycolatopsis
orientalis,  methanolica M. smegmatis. TSB supple-
mented 2.5  NaCl used Salinospora tropica, YEME:TSB (1:1) (39) Streptomyces strains Saccharopolyspora erythrea. LB used R. equi Rhodococcus rhodochrous LBP (3) used           Figure 1. Introduction E. coli codA::upp cassette, encoding CD R. erythropolis R. jostii. Minimal regeneration medium     UPRT, confers 5-FC sensitivity R. equi strain RE1. Panels wild
                                                               type strain RE1, recombinant strain RE1 containing pSET152, recom-
(MRM) consisted K2SO4 (0.25 g/l), (NH4)2SO4 (2 g/l),        binant strain RE1 containing plasmid pSET-codA::upp streaked MgCl26H20 (0.6 g/l), 2-[(hydroxyl-1, 1-bis (hydroxy-          mineral acetate agar (MM-Ac) containing   addition, (B) 5-FC
methyl)ethyl)amino] ethanesulfonic acid; TES (5.73 g/l)        (100 mg/ml) (C) 5-FU (50 mg/ml) (D) LB agar containing trace elements (39). Sucrose (10.3  w/v) L-proline     5-FC (100 mg/ml).
(0.3  w/v) added MRM medium Streptomyces
strains, omitted strains. Glucose (20 mM) used carbon energy source, Rhodococcus strains grown presence acetate (2 g/l). Autoclaved MRM supplemented KH2PO4 (0.1 g/l), CaCl22H20 (3 g/l) NaOH (0.28 g/l). agar plates 2  granulated agar added. Filter-
sterilized thiamine (40 mg/ml) added autoclaved
MRM medium growth Rhodococcus strains. 5-FC 5-FU freshly prepared 10 mg/ml stocks distilled water, dissolved heating 508C added autoclaved medium.
                                                               Figure 2. pSET152 derived integrative plasmids used introduce
RESULTS DISCUSSION                                           codA (B) codA::upp cassette R. equi RE1, expressed
                                                               control aphII kanamycin resistance cassette promoter
CD-UPRT mediated 5-fluorocytosine sensitivity                  (PaphII). apramycin resistance cassette (aac(3)IV), R. equi strain RE1                                          Streptomyces PhiC31 integrase gene (int) RP4 origin transfer
                                                               (oriT) indicated. obvious prerequisite applicability 5-FC
based conditionally lethal positive selection nat-
ural resistance R. equi strain RE1 5-FC. test  R. equi RE1 streaked acetate mineral
(MM-Ac) agar plates supplemented 5-FC 5-FU incubated 3 days 308C. Examination plates revealed R. equi resistant high concen-
trations 5-FC (100 mg/ml), highly sensitive lower concentration 5-FU (50 mg/ml), indicating feasibility developing 5-FC based positive selection R. equi (Figure 1).  examined expression E. coli genes codA upp R. equi confer sensitivity 5-FC act suicide marker. integrative E. coli-Streptomyces shut-     Figure 3. Schematic representation non-replicative plasmid
tle vector pSET152 provided stable convenient vehi-      pSelAct used generate unmarked frame gene deletions R. equi
cle introduce codA functional codA::upp fusion    RE1. Restriction sites indicated unique.
 PAGE 5 10                                                         Nucleic Acids Research, 2008, Vol. 36,  22 e151

 R. equi genome (40,41). aphII promoter region       SupA 54 amino acids SupB, separated kanamycin resistance cassette (Pkan) used           6 bp SmaI restriction site. ï¬?rst supA
drive expression codA codA::upp, respectively.       supB, respectively, left intact ensure proper resulting integrative plasmids, pSET-Pkan-codA             expression downstream genes mce4 operon. pSET-Pkan-codAupp (Figure 2), mobilized sepa-         Introduction plasmid pSelAct-supAB R. equi
rately electroporation R. equi RE1. Transformants        RE1, selecting apramycin resistance, resulted 29
harboring pSET-Pkan-codA pSET-Pkan-                  transformants selected grown non-
codAupp streaked MM-Ac agar plates                   selectively overnight 20 h LB medium  e. lacking
(Figure 1A), MM-Ac agar plates supplemented               apramycin 5-FC). Aliquots (100 ml) overnight
100 mg/ml 5-FC (Figure 1B), MM-Ac agar plates sup-          cultures plated 10 1 10 3 dilutions MM-
plemented 50 mg/ml 5-FU (Figure 1C) incubated         Ac agar plates supplemented 100 mg/ml 5-FC 3 days 308C. presence codA::upp cassette     incubated 3 days 308C. Conï¬‚uent growth 5-FC
rendered R. equi sensitive 5-FC, expression      selection plates obtained transformants.
codA did result 5-FC sensitivity (Figure 1B).     Conceivably, codA::upp suicide cassette inac-
Growth R. equi strain carrying codA::upp cassette   tivated transformant spontaneous mutation nonselective conditions similar wild      transposon insertion, reported occur type (Figure 1A), indicating expression condition-     sacB counter-selection (3,42). Typically, >102 colonies
ally lethal detrimental cells 5-FC          grew 10 2 plate 50 colonies replica
omitted medium. Importantly, 5-FC selection        picked LB agar apramycin select observed complex agar media (LB) used             5-FCR/ApraS colonies. frequency 5-FCR/ApraS
(Figure 1D). repression pyrimi-      colonies transformants varied
dine salvage pathway aï¬€ecting 5-FC uptake.                     70â€“90 , indicating suicide cassette    enable generation unmarked frame gene          inactivated 10â€“30  5-FCR/ApraS colonies.
deletions R. equi using CD-UPRT based 5-FC condi-           transformant, eighteen 5-FCR/ApraS colonies
tional lethality, developed non-replicative sui-     checked colony PCR presence cide vector designated pSelAct (Figure 3; Materials        mutant supAB genotype using PCR oligonucleo- Methods section). Vector pSelAct small (5.6 kb)       tides 6 7 amplifying supAB genes (Table 1,
conjugative plasmid based pBlueScript(II)KS, harbor-        Figure 4). eighteen FCR/ApraS colonies gave
ing aac(3)IV cassette apramycin resistance    PCR product expected size (231 bp) used E. coli R. equi. vector contains     selected characterization. Genomic DNA MCS unique restriction sites cloning          isolated supAB mutants subjected ï¬‚anking regions gene using lacZ depen-      PCR analysis supAB locus  
dent blue-white screening E. coli.                          stream ï¬‚anking regions supAB (Figure 5, Table 1                                                                oligonucleotides used). conï¬?rmed presence Unmarked frame gene deletion supAB R. equi            genuine supAB gene deletion cases revealed                                                                aberrant genomic rearrangements supAB locus BLAST search supA (ro04696), supB (ro04697)         (Figure 5). mutant strain chosen, designated R. mce4 (ro04698-ro04703) genes R. jostii RHA1,            equi RE1supAB, used predicted encode cholesterol uptake machinery           characterization.
(6), revealed genes apparent operonic
organization highly conserved R. equi 103S
                                                               Phenotypical analysis functional complementation
genome (Figure 4; http://www.sanger.ac.uk/Projects/
                                                               R. equi RE1"supAB mutant
R_equi/). Highest amino acid identities observed SupA (94 ) SupB (89 ), mce4                R. equi RE1 wild type RE1supAB mutant strain
encoded proteins Mce4A-Mce4F showed lower identities           grown MM-Ac liquid medium used inocu-
(57â€“71 ) (Figure 4).                                           late MM-cholesterol liquid medium. RE1supAB
   supA supB genes ï¬?rst genes       mutant completely blocked growth cholesterol
mce4 operon, encode cholesterol permease           sole carbon energy source (Figure 6). Growth subunits (Figure 4). demonstrate speciï¬?c role          acetate steroid substrate 4-androstene-3,17-dione
supAB cholesterol catabolism, aimed selec-     (AD) unaï¬€ected comparable wild type
tive inactivation, aï¬€ecting expression          strain (data shown). indicated supAB downstream genes. prompted develop              essential cholesterol catabolism, probably acting unmarked frame gene deletion R. equi             permease subunits cholesterol ABC transporter.
based counter-selection 5-FC. upstream         results fully consistent phenotype downstream ï¬‚anking regions (1.5 kb) supAB genes        supAB mutant strain RHA1 (6). ampliï¬?ed PCR ligated pSelAct generat-            ensure growth deï¬?ciency ing pSelAct-supAB (Figure 4; Table 1 primers).       RE1supAB mutant solely deletion construct used generate supAB mutant,             supAB genes, 3163-bp DNA fragment carrying
reducing wild type supA (765 nt) supB (852 nt)         wild-type supAB genes introduced electropora-
genes, encompassing 1637 bp, single frame open-        tion RE1supAB mutant. DNA fragment
reading-frame 231 bp, encoding ï¬?rst 20 amino acid       obtained PCR strain RE1 wild type DNA
 e151 Nucleic Acids Research, 2008, Vol. 36,  22                                                                               PAGE 6 10




Figure 4.   Schematic overview molecular organization mce4 gene clusters R. jostii RHA1 R. equi 103S. Percentages indicate
amino acid sequence identities Mce4 proteins R. jostii RHA1 R. equi RE1. (B) Construction mutagenic plasmid pSelAct-
supAB used generate unmarked supAB gene deletion mutant R. equi RE1. Small black arrows numbers indicate PCR oligonu-
cleotides used study (Table 1) site annealing. (C) Molecular organization mce4 locus R. equi RE1 following
integration pSelAct-supAB single homologous recombination, second homologous recombinant event 5-FC counter-selection,
resulting supAB gene deletion.
 PAGE 7 10                                                                        Nucleic Acids Research, 2008, Vol. 36,  22 e151


Table 1. Oligonucleotides used study
   PCR amplicon                                             Size (bp)         Oligonucleotide sequence (nr.)

1    Upstream region supAB (deletion construct)               1592              supABequiUP-F ATCGCGAGGTCAGCTTGGAG (1)
                                                                                supABequiUP-R CCCGGGCGCCGACATCGCGAAGAATC (2)
2    Downstream region supAB (deletion construct)             1470              supABequiDOWN-F CCCGGGCTCATCCACACCTACTACGG (3)
                                                                                supABequiDOWN-R ACTAGTGAGCTGCTGAATCTGAACTGG (4)
3    Upstream region supAB (conï¬?rmation deletion mutant)      1786 (wt: 3192)   supABequiContrUP-F CGGGAGTGCGTAGATGAGTGCA (5)
                                                                                supABequiContr-R TTATCCCGAAAGGTTGAAGTTG (6)
4    Downstream region supAB (conï¬?rmation deletion mutant)    1570 (wt: 2976)   supABequiContr-F GTGGTCGACCTCCTCGAGGTAC (7)
                                                                                supABequiContrDOWN-R GGACTTGAGCCCGGAGGCATCG (8)
5    supAB genes (conï¬?rmation deletion mutant)                 231 (wt: 1637)   supABequiContr-F GTGGTCGACCTCCTCGAGGTAC (7)
                                                                                supABequiContr-R TTATCCCGAAAGGTTGAAGTTG (6)
6    supAB genes (complementation supAB mutant)              3163              supABequiUP-F ATCGCGAGGTCAGCTTGGAG (1)
                                                                                supABequiContr-R TTATCCCGAAAGGTTGAAGTTG (6)
7    aphII promoter region                                     367              Pkan-F AGCTTCACGCTGCCGCAAGCACT
                                                                                Pkan-E5-R GATATCATGCGAAACGATCCTCATCCTG
8    Pkan-codA cassette                                       1733              Pkan-F AGCTTCACGCTGCCGCAAGCACT
                                                                                codA-R2 GTCAACGTTTGTAATCGATGGCTTCT
9    vapA                                                      408              vapA-F GCAGCAGTGCGATTCTCAATAG (9)
                                                                                vapA-R TAACTCCACCGGACTGGATATG (10)

Primer numbering used text shown brackets following nucleotide sequence.




Figure 5. PCR analysis wild type R. equi strain RE1 (wt) supAB gene deletion mutants R. equi strain RE1 (1 2). Panels ampliï¬?cation   supAB locus [6 + 7], (II) upstream region supAB [5 + 6], (III) downstream region supAB [7 + 8], (IV) vapA
virulence gene [9 + 10]. oligonucleotides used mentioned brackets described Table 1 Figure 4.


using oligonucleotides 1 6 (Table 1, Figure 4) cloned integrative plasmid SET152, resulting pSET-supAB. cholesterol growth negative phenotype RE1supAB mutant harboring pSET-supAB fully complemented, restoring growth cholesterol levels comparable wild type (Figure 6). conclude supAB deletion did exert polar eï¬€ects expression genes mce4 operon.
   data developed novel, simple eï¬ƒcient method generate unmarked frame gene
deletions R. equi, based 5-FC lethality pre-
sence E. coli codA::upp fusion gene.

Deletion supAB does affect R. equi RE1 survival macrophages
Intracellular survival proliferation R. equi
RE1supAB mutant human monocyte cell line
U937 compared wild type strain RE1
(Figure 7). avirulent, plasmid free strain R. equi
103 (43) included negative control macro-                      Figure 6. Growth curves mineral medium supplemented choles-
phage survival (Figure 7). results revealed                    terol (0.5 g/l) R. equi RE1 wild-type (ï¬?lled diamond), RE1 supAB
RE1supAB mutant able survive proliferate                      mutant strain (ï¬?lled square), RE1 supAB + pSET-supAB complemen-
                                                                            ted strain (ï¬?lled triangle), RE1 supAB + pSET152 control strain
macrophages comparable wild-type parent strain                       (x). Protein content (mg/l) culture used measure RE1. contrast, avirulent strain 103 failed pro-                   biomass formation. data represent averages indepen-
liferate, resulting reduced numbers intracellular                     dent experiments.
 e151 Nucleic Acids Research, 2008, Vol. 36,  22                                                                       PAGE 8 10


bacteria time (Figure 7). results indicate               Actinobacteria generally 5-FC resistant
cholesterol metabolism essential macrophage                 CD-UPRT based 5-FC selection survival R. equi RE1 suggest cholesterol                   useful asset generation unmarked frame gene
metabolism important virulence R. equi                   deletions actinobacteria. examine RE1 vivo. observations consistent                CD-UPRT selection potentially eï¬€ective counter-
ï¬?nding ChoE important virulence                  selectable marker family microorganisms, R. equi (28).                                                          tested sensitivity actinobacteria                                                                        5-FC 5-FU. wide selection actinobacterial strains
                                                                       grown complex medium late exponential/
                                                                       early stationary phase plated 10-fold dilutions
                                                                       mineral selection media containing increasing 
                                                                       centrations 5-FC 5-FU (Table 2). tested strains
                                                                       generally resistant high concentrations 5-FC
                                                                       (100 mg/ml), highly sensitive lower concentrations
                                                                       5-FU (20â€“50 mg/ml), indicating feasibility devel-
                                                                       oping 5-FC based positive selection                                                                        actinobacteria.

                                                                       ACKNOWLEDGEMENTS
                                                                       sequence data R. equi 103S produced                                                                        R. equi Sequencing Group Sanger Institute                                                                        obtained ftp://ftp.sanger.ac.uk/pub/pathogens 
                                                                       thank J  Salas (Oviedo, Spain), E.M.H.
                                                                       Wellington (Warwick, UK) M. Fukuda (Nagaoka,
                                                                       Japan) providing strains.

Figure 7. Survival proliferation R. equi strains human
monocyte cell line U937. Macrophage cell suspensions infected
                                                                       FUNDING wild type virulent strain R. equi RE1 (ï¬?lled diamond), mutant     Intervet Schering-Plough Animal Health, Boxmeer,
strain R. equi RE1supAB (ï¬?lled square) non-virulent (control)
strain R. equi 103 (ï¬?lled triangle). Following 1-h incubation                                                                        Netherlands. Funding open access charge:
allow phagocytosis, cells washed treated gentamycin   Groningen Biomolecular Sciences Biotechnology
kill remaining extra-cellular bacteria. numbers intracellular   Institute (GBB), University Groningen, bacteria determined plate counts following macrophage lysis.   Netherlands. data represent averages independent experiments.
Plate counts carried duplicate.                            Conï¬‚ict statement. declared.


Table 2. Growth actinobacteria MRM mineral agar media supplemented diï¬€erent concentrations 5-FC 5-FU

Strain                                                  5-FC (mg/ml)                 5-FU (mg/ml)          Reference/origin

                                             0         20       50     100      20       50         100

Amycolatopsis methanolica NCIB11946          ++        +                        â€“        â€“          â€“      (44)
Amycolatopsis orientalis ATCC 19795          ++        ++       +      +                                   ATCC
Arthrobacter globiformis DSM 20124           ++        ++       +      +        â€“        â€“          â€“      DSMZ
Corynebacterium glutamicum ATCC 13032        ++        +                                 â€“          â€“      ATCC
Mycobacterium smegmatis mc2155               ++        +                        â€“        â€“          â€“      (45)
Rhodococcus rhodochrous DSM 43269            ++        ++       ++     ++       +        â€“          â€“      DSMZ
Rhodococcus erythropolis SQ1                 ++        ++       ++     ++       â€“        â€“          â€“      (46)
Rhodococcus jostii RHA1                      ++        ++       ++     ++       +                   â€“      M. Fukuda, Nagaoka (Japan)
Rhodococcus equi RE1                         ++        ++       ++     ++       +        â€“          â€“      Schering-Plough, Netherlands
Salinospora tropica                          ++        ++       ++     ++                                  DSMZ
Saccharopolyspora erythraea                  ++        ++       ++     ++       â€“        â€“          â€“      DSMZ
Streptomyces albus J1074                     ++        ++       ++     ++       â€“        â€“          â€“      (47)
Streptomyces avermitilis MA-4680             ++        ++       ++     ++       ++       ++         ++     ATCC (ATCC 31267)
Streptomyces coelicolor M145                 ++        ++       ++     ++       â€“        â€“          â€“      (39)
Streptomyces griseus DSM40236                ++        ++       ++     ++       â€“        â€“          â€“      DSMZ
Streptomyces lividans TK23                   ++        ++       ++     ++       â€“        â€“          â€“      (39)
Streptomyces scabies ISP5078                 ++        ++       ++     +        â€“        â€“          â€“      Wellington, Warwick (UK)
Streptomyces tendae TuÂ¨ 901/8c               ++        ++       ++     +        +        â€“          â€“      (48)

Symbols indicate growth (++), moderate growth (+), slight/minor growth ( ) growth (â€“).
ATCC, American Type Culture Collection; DSMZ, Deutsche Sammlung von Mikroorganismen und Zellkulturen.
 PAGE 9 10                                                                      Nucleic Acids Research, 2008, Vol. 36,  22 e151


REFERENCES                                                                     cytotoxicity 5-ï¬‚uorocytosine. . FEMS Microbiol. Lett.,
                                                                               167, 41â€“49.
 1. Ried,J.L. Collmer  (1987) nptI-sacB-sacR cartridge        20. Hughes,L.E., Beck,D  Oâ€™Donovan,G  (2005)
    constructing directed, unmarked mutations gram-negative                 Pathways pyrimidine salvage Streptomyces. Curr. Microbiol.,
    bacteria marker exchange-eviction mutagenesis. Gene,                    50, 8â€“10.
    57, 239â€“246.                                                           21. Tsukamura,M. (1981) Diï¬€erentiation genera
 2. Reyrat,J.M., Pelicic,V., Gicquel,B. Rappuoli,R. (1998)                 Mycobacterium, Rhodococcus Nocardia susceptibility     Counterselectable markers: untapped tools bacterial genetics           5-ï¬‚uorouracil. J. Gen. Microbiol., 125, 205â€“208.
    pathogenesis. Infect. Immun., 66, 4011â€“4017.                       22. Tsukamura,M., Komatsuzaki,C., Sakai,R., Kaneda,K., Kudo,T.
 3. Van der Geize,R., Hessels,G , Van Gerwen,R., Van der Meijden,P.          Seino  (1988) Mesenteric lymphadenitis swine caused     Dijkhuizen,L. (2001) Unmarked gene deletion mutagenesis             Rhodococcus sputi. J. Clin. Microbiol., 26, 155â€“157.
    kstD, encoding 3-ketosteroid 1-dehydrogenase, Rhodococcus          23. Prescott,J.F. (1991) Rhodococcus equi: animal human
    erythropolis SQ1 using sacB counter-selectable marker. FEMS             pathogen. Clin. Microbiol. Rev., 4, 20â€“34.
    Microbiol. Lett., 205, 197â€“202.                                        24. Meijer,W.G. Prescott,J.F. (2004) Rhodococcus equi. Vet. Res.,
 4. Nga,D.P., Altenbuchner,J. Heiss,G.S. (2004) NpdR, repressor          35, 383â€“396.
    involved 2,4,6-trinitrophenol degradation Rhodococcus opacus     25. Ahmad,S., Roy,P.K., Basu,S.K. Johri,B.N. (1993) Cholesterol
    HL PM-1. J. Bacteriol., 186, 98â€“103.                                       chain cleavage immobilized cells Rhodococcus equi
 5. Sharp,J.O., Sales,C.M., LeBlanc,J.C., Liu,J., Wood,T.K.,                   DSM89-133. Indian J. Exp. Biol., 31, 319â€“322.
    Eltis,L.D., Mohn,W.W. Alvarez-Cohen,L. (2007) inducible         26. Murohisa,T. Iida,M. (1993) new intermediates micro-
    propane monooxygenase responsible N-nitrosodimethylamine            bial chain degradation b-sitosterol. J. Ferment. Bioeng.,
    degradation Rhodococcus sp. strain RHAI. Appl. Environ.                 76, 174â€“177.
    Microbiol., 73, 6930â€“6938.                                             27. Navas,J., GonzaÂ´lez-Zorn,B., LadroÂ´n,N., Garrido,P. VaÂ´zquez-
 6. Van der Geize,R., Yam,K., Heuser,T., Wilbrink,M.H., Hara,H.,               Boland,J  (2001) Identiï¬?cation mutagenesis allelic
    Anderton,M.C., Sim,E., Dijkhuizen,L., Davies,J.E., Mohn,W.W.               exchange choE, encoding cholesterol oxidase     et al. (2007) gene cluster encoding cholesterol catabolism          intracellular pathogen Rhodococcus equi. J. Bacteriol.,
    soil actinomycete provides insight Mycobacterium tuberculosis         183, 4796â€“4805.
    survival macrophages. Proc. Natl Acad. Sci. USA,                    28. Pei,Y., Dupont,C., Sydor,T., Haas  Prescott,J.F. (2006)
    104, 1947â€“1952.                                                            Cholesterol oxidase (ChoE) important virulence  7. JaÂ¨ger,W., SchaÂ¨fer , PuÂ¨hler , Labes,G. Wohlleben,W. (1992)       Rhodococcus equi. Vet. Microbiol., 118, 240â€“246.
    Expression Bacillus subtilis sacB gene leads sucrose         29. McLeod,M.P., Warren,R.L., Hsiao,W.W., Araki,N., Myhre,M.,
    sensitivity gram-positive bacterium Corynebacterium                 Fernandes,C., Miyazawa,D., Wong,W., Lillquist L., Wang,D.
    glutamicum Streptomyces lividans. J. Bacteriol.,                et al. (2006) complete genome Rhodococcus sp. RHA1
    174, 5462â€“5465.                                                            provides insights catabolic powerhouse. Proc. Natl Acad. Sci.
 8. Zhang,X , Yan,X., Cui L., Hong,Q. Li,S.P. (2006) mazF,           USA, 103, 15582â€“15587.
    novel counter-selectable marker unmarked chromosomal               30. Rengarajan,J., Bloom,B.R. Rubin,E.J. (2005) Genome-wide
    manipulation Bacillus subtilis. Nucleic Acids Res., 34, e71.            requirements Mycobacterium tuberculosis adaptation  9. Van Wezel,G.P. Bibb,M.J. (1996) novel plasmid vector            survival macrophages. Proc. Natl Acad. Sci. USA,
    uses glucose kinase gene (glkA) positive selection          102, 8327â€“8332.
    stable gene disruptants Streptomyces. Gene, 182, 229â€“230.           31. Joshi,S.M., Pandey K., Capite,N., Fortune,S.M., Rubin,E.J. 10. Hosted,T.J. Baltz,R.H. (1997) Use rpsL dominance                Sassetti,C.M. (2006) Characterization mycobacterial virulence
    selection gene replacement Streptomyces roseosporus. J.             genes genetic interaction mapping. Proc. Natl Acad. Sci.
    Bacteriol., 179, 180â€“186.                                                  USA, 103, 11760â€“11765.
11. Knipfer,N., Seth  Shrader,T.E. (1997) Unmarked gene inte-        32. Pandey K. Sassetti,C.M. (2008) Mycobacterial persistence
    gration chromosome Mycobacterium smegmatis                 requires utilization host cholesterol. Proc. Natl Acad. Sci.
    precise replacement pyrF gene. Plasmid, 37, 129â€“140.                USA, 105, 4376â€“4380.
12. Fabret,C., Ehrlich,S.D. Noirot,P. (2002) new mutation            33. Jain,S., Bloom,B.R. Hondalus,M.K. (2003) Deletion     delivery genome-scale approaches Bacillus subtilis.          vapA encoding Virulence Associated Protein attenuates     Mol. Microbiol., 46, 25â€“36.                                                intracellular actinomycete Rhodococcus equi. Mol. Microbiol.,
13. Gust,B., Challis,G.L., Fowler,K., Kieser,T. Chater,K.F. (2003)         50, 115â€“128.
    PCR-targeted Streptomyces gene replacement identiï¬?es protein         34. Pei,Y., Nicholson,V., Woods,K. Prescott,J.F. (2007)
    domain needed biosynthesis sesquiterpene soil odor              Immunization intrabronchial administration 1-week-old foals
    geosmin. Proc. Natl Acad. Sci. USA, 100, 1541â€“1546.                        unmarked double gene disruption strain Rhodococcus equi
14. Fedoryshyn,M., Petzke,L., Welle,E., Bechthold                        strain 103+. Vet. Microbiol., 125, 100â€“110.
    Luzhetskyy  (2008) Marker removal actinomycetes genome          35. Pei,Y., Parreira,V., Nicholson,V.M. Prescott,J.F. (2007)
    using Flp recombinase. Gene, 419, 43â€“47.                                   Mutation virulence assessment chromosomal genes 15. Andersen,L., Kilstrup,M. Neuhard,J. (1989) Pyrimidine, purine          Rhodococcus equi 103.  J. Vet. Res., 71, 1â€“7.
    nitrogen control cytosine deaminase synthesis Escherichia    36. Vishniac,W. Santer,M. (1957) thiobacilli. Bacteriol. Rev.,
    coli K 12. Involvement glnLG purR genes regu-            21, 195â€“213.
    lation codA expression. Arch. Microbiol., 152, 115â€“118.             37. Van der Geize,R., Hessels,G , Van Gerwen,R., Van der Meijden,P.
16. Danielsen,S., Kilstrup,M., Barilla,K., Jochimsen,B. Neuhard,J.         Dijkhuizen,L. (2002) Molecular functional characterization
    (1992) Characterization Escherichia coli codBA operon               kshA kshB, encoding components 3-ketosteroid
    encoding cytosine permease cytosine deaminase. Mol.                    9a-hydroxylase, class IA monooxygenase, Rhodococcus
    Microbiol., 6, 1335â€“1344.                                                  erythropolis SQ1. Mol. Microbiol., 45, 1007â€“1018.
17. Heidelberger,C., Danenberg,P.V. Moran,R.G. (1983)                  38. Sundstrom,C. Nilsson,K. (1976) Establishment character-
    Fluorinated pyrimidines nucleosides. Adv. Enzymol. Relat.        ization human histiocytic lymphoma cell line (U937). Int. J.
    Areas Mol. Biol., 54, 58â€“119.                                              Cancer, 17, 565â€“577.
18. Mullen,C., Kilstrup,M. Blaese,R.M. (1992) Transfer          39. Kieser,T., Bibb,M.J., Buttner,M.J., Chater,K.F.     bacterial gene cytosine deaminase mammalian cells confers           Hopwood,D  (2000) Practical Streptomyces Genetics, John Innes
    lethal sensitivity 5-ï¬‚uorocytosine: negative selection         Foundation, Norwich, UK.
    Proc. Natl Acad. Sci. USA, 89, 33â€“37.                                  40. Bierman,M., Logan,R., Oâ€™Brien,K., Seno,E.T., Rao,R.N. 19. Tiraby,M., Cazaux,C., Baron,M., Drocourt,D., Reynes,J.P.               Schoner,B.E. (1992) Plasmid cloning vectors conjugal
    Tiraby,G. (1998) Concomitant expression E. coli cytosine                transfer DNA Escherichia coli Streptomyces spp. Gene,
    deaminase uracil phosphoribosyltransferase improves                116, 43â€“4